Member Exclusive Bioprinting News

‘TumorPrint’ project for the printing of human cancer models receives EU funding

CELLINK (Gothenburg, Sweden) have been awarded a €2.5 million grant from the European Commission to develop and commercialize their project, ‘TumorPrint’, for the benefit of research into cancer tumors and their cellular reactions to different pharmaceutical compounds.

Please sign in or register for FREE

No comments yet.